In 2022, the worldwide medical waste management system market is anticipated to be worth $7,592.9 million USD. Medical waste is waste generated at medical facility centres and life science processing facilities. Medical waste coming through healthcare activities is inclusive of chemicals, blood, body parts, a wide range of materials, diagnostic samples, soiled dressings, pharmaceuticals, radioactive …
Category Archives: Healthcare Trends
Medical Terahertz Technology Market is expected to increase at a CAGR 17.1% through 2032
According to a report published by FMI, the global medical terahertz technology market will be valued at US$ 135.29 Million in 2022. It is expected to grow at a CAGR of 17.1% during the forecast period, reaching a value of US$ 768.05 Million by 2032. A fast-growing field of terahertz technology is driving market growth …
Endocrine Testing Market Anticipated to reach US$ 5735 Million by 2032 | FMI
The global endocrine testing market is currently valued at US$ 2536.7 Million and is projected to grow at a CAGR of 8.5%. As diabetes cases become more prevalent, the global market is expected to reach a market value of US$ 5735 Million by the year 2032. The growing prevalence of endocrine disorders and the advancement …
Continue reading “Endocrine Testing Market Anticipated to reach US$ 5735 Million by 2032 | FMI”
Cytokine Release Syndrome Management Market is expected to be worth US$ 44.6 billion by 2033 | FMI Analyst
The global Cytokine Release Syndrome Management Market is expected to be worth US$ 23.32 billion in 2023, growing at a 6.7% CAGR between 2023 and 2033. In the coming years, the market for CRS management is expected to grow due to an increase in the number of autoimmune diseases and cancers. The development of novel …
Fucosidosis Therapeutics Market is expected to reach US$ 17.91 Million by 2033 | FMI Study
The global Fucosidosis Therapeutics Market is expected to garner a market value of US$ 10 Million in 2023 and is expected to accumulate a market value of US$ 17.91 Million by registering a CAGR of 6% in the forecast period 2023 to 2033. The market for Fucosidosis Therapeutics registered a CAGR of 4% in the …
Idiopathic Pulmonary Fibrosis Management Market is expected to reach US$ 3649.90 Million by 2033 | FMI
The global Idiopathic Pulmonary Fibrosis Management Market is expected to generate a market value of US$ 3145 Million in 2023 and a market value of US$ 3649.90 Million by 2033, with a CAGR of 1.5% from 2023 to 2033. The increasing prevalence of the disease in males around the world has contributed to the growth …
The Global Encephalitis Treatment Market Is Expected to Register Growth at 5.4% CAGR through 2033 | FMI Study
The global Encephalitis Treatment Market is currently valued at US$ 20.14 billion in 2023, with a CAGR of 5.4% expected. Because of technological advancements in healthcare, the market is expected to reach US$ 34.08 billion by 2033. The major factor attributing to the growth of the market is the high mortality and morbidity rate caused …
Cardiovascular Ultrasound Market is expected to reach a US$ 2.6 billion valuation by 2033 | FMI Study
The Cardiovascular Ultrasound Market revenues were estimated at US$ 1.2 Billion in 2021 and is anticipated to grow at a CAGR of 7.2% from 2022-2032, according to a recently published Future Market Insights report. By the end of 2032, the market is expected to reach US$ 2.6 Billion. The market is predicted to grow as …
Liver Fibrosis Treatment Market to surge at an 11% CAGR until 2033, reaching US$ 46.65 billion | FMI Study
The global Liver Fibrosis Treatment Market is anticipated to exceed a remarkable valuation of US$ 16.43 billion in 2023, with a compound annual growth rate (CAGR) of 11% projected from 2023 to 2033. The rising prevalence of undesirable outcomes such as hepatitis B or C virus infection, an impaired immune system due to co-infection with …
Next Generation Immunotherapies Market to reach US$ 268.84 billion by 2033, Monoclonal Antibodies were Primary Drug Class | FMI Report
The global Next Generation Immunotherapies Market is estimated to exceed a spectacular valuation of US$ 268.84 billion in 2033, with a compound annual growth rate (CAGR) of 7.5% projected from 2023 to 2033. The vast majority of present immunotherapies, such as checkpoint inhibitors, seek to enhance the immune system’s adaptive response, precisely cytotoxic T cells, …